000			03869nam a22004935i 4500
001			978-3-642-38508-7
003			DE-He213
005			20140220082518.0
007			cr nn 008mamaa
008			131203s2014 gw | s |||| 0|eng d
020			_a9783642385087 _9978-3-642-38508-7
024	7		_a10.1007/978-3-642-38508-7 _2doi
050		4	_aRD592.5-596
072		7	_aMNN _2bicssc
072		7	_aMED085010 _2bisacsh
082	0	4	_a617.48 _223
100	1		_aTurgut, Mehmet. _eeditor.
245	1	0	_aPituitary Apoplexy _h[electronic resource] / _cedited by Mehmet Turgut, Ashok Kumar Mahapatra, Michael Powell, Natarajan Muthukumar.
264		1	_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2014.
300			_aXIV, 188 p. 32 illus., 20 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aIntroduction: Definition, History, Frequency, Histopathology and Pathophysiology of Pituitary Apoplexy. Overview: Conservative versus Surgical Decompression for Pituitary Apoplexy. Tumours Types which Show Apoplexy: Predisposing factors for Pituitary Apoplexy -- Non-functioning tumour apoplexy -- Apoplexy in previously known tumours -- Post-operative Pituitary Apoplexy. Clinical Features: Clinical features of Pituitary Apoplexy -- Subarachnoid hemorrhage with Pituitary Adenoma -- Cerebral ischaemia in Pituitary Apoplexy. Visual and Endocrine Assessment: Visual acuity, eye movements and visual fields -- Visual outcome following Pituitary Apoplexy.- Preoperative endocrine function and fluid electrolyte balance -- Endocrinopathies and other biochemical abnormalities in Pituitary Apoplexy. Mimicking Conditions: Carotid artery aneurysm -- Hypothalamic lymphoma -- Rathke's cleft cysts mimicking Pituitary Apoplexy. Management: Conservative management of Pituitary Apoplexy -- Surgical decompression for Pituitary Apoplexy -- Timing of surgery and outcome in Pituitary Apoplexy. Complications: Subarachnoid hemorrhage after transsphenoidal surgery.
520			_aPituitary apoplexy is a rare and life-threatening complication that occurs in 0.6–10.5% of all patients with pituitary adenomas. Unfortunately, pituitary apoplexy is often misdiagnosed before surgery. Furthermore, in spite of all the advances in imaging techniques and therapeutic methods, its optimal management is still controversial owing to the limited individual experience and the very variable clinical course of the condition, which ranges from asymptomatic to critical illness with visual loss and subarachnoid hemorrhage. The management of visual dysfunction in particular remains a subject of debate.   This book provides an in-depth review of knowledge of the management of pituitary apoplexy, with an emphasis on clinical and neuroradiological findings and treatment modalities, medical and surgical. In addition, it supplies clinicians and investigators with detailed information on current evidence and considers future areas of investigation and innovative therapeutic philosophies. Both the editors and the authors are leading international authorities in the field.
650		0	_aMedicine.
650		0	_aEndocrinology.
650		0	_aNeurosurgery.
650		0	_aOphthalmology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aNeurosurgery.
650	2	4	_aEndocrinology.
650	2	4	_aOphthalmology.
700	1		_aMahapatra, Ashok Kumar. _eeditor.
700	1		_aPowell, Michael. _eeditor.
700	1		_aMuthukumar, Natarajan. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783642385070
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-642-38508-7
912			_aZDB-2-SME
999			_c93250 _d93250